Insider Trades - GLENVIEW CAPITAL MANAGEMENT, LLC

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GLENVIEW CAPITAL MANAGEMENT, LLC: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
Health Management Associates, I Beneficial Owner (10% or more) NYSE:HMA (historical quotes, profile, SEC, other insiders)	10-Jan-13	37,757,583	Indirect
Tenet Healthcare Corporation Co Beneficial Owner (10% or more) NYSE:THC (historical quotes, profile, SEC, other insiders)	14-May-13	9,839,339	Indirect

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
14-May-13 *4,000,000 THC Sale at $47.75 per share.
(Proceeds of $191,000,000)
10-Jan-13 *700,000 HMA Purchase at $9.13 per share.
(Cost of $6,391,000)
9-Jan-13 *1,771,780 HMA Purchase at $9.09 per share.
(Cost of $16,105,480)
8-Jan-13 *226,300 HMA Purchase at $9.14 per share.
(Cost of $2,068,382)
28-Dec-12 *500,000 HMA Purchase at $9 per share.
(Cost of $4,500,000)
27-Dec-12 *500,000 HMA Purchase at $9 per share.
(Cost of $4,500,000)
21-Dec-12 *450,000 HMA Purchase at $9.07 per share.
(Cost of $4,081,500)
20-Dec-12 *4,205,227 HMA Purchase at $9.19 per share.
(Cost of $38,646,036)
19-Dec-12 *775,000 HMA Purchase at $9 per share.
(Cost of $6,975,000)
19-Dec-12 *28,629,276 HMA Statement of Ownership
19-Oct-12 *200,000 THC Purchase at $23.53 per share.
(Cost of $4,706,000)
16-Oct-12 *398,734 THC Purchase at $23.99 per share.
(Cost of $9,565,628)
15-Oct-12 *34,649 THC Purchase at $23.91 per share.
(Cost of $828,457)
* Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
14-May-13	*4,000,000	THC	Sale at $47.75 per share. (Proceeds of $191,000,000)
10-Jan-13	*700,000	HMA	Purchase at $9.13 per share. (Cost of $6,391,000)
9-Jan-13	*1,771,780	HMA	Purchase at $9.09 per share. (Cost of $16,105,480)
8-Jan-13	*226,300	HMA	Purchase at $9.14 per share. (Cost of $2,068,382)
28-Dec-12	*500,000	HMA	Purchase at $9 per share. (Cost of $4,500,000)
27-Dec-12	*500,000	HMA	Purchase at $9 per share. (Cost of $4,500,000)
21-Dec-12	*450,000	HMA	Purchase at $9.07 per share. (Cost of $4,081,500)
20-Dec-12	*4,205,227	HMA	Purchase at $9.19 per share. (Cost of $38,646,036)
19-Dec-12	*775,000	HMA	Purchase at $9 per share. (Cost of $6,975,000)
19-Dec-12	*28,629,276	HMA	Statement of Ownership
19-Oct-12	*200,000	THC	Purchase at $23.53 per share. (Cost of $4,706,000)
16-Oct-12	*398,734	THC	Purchase at $23.99 per share. (Cost of $9,565,628)
15-Oct-12	*34,649	THC	Purchase at $23.91 per share. (Cost of $828,457)